
Current management strategy of hepatocellular carcinoma
Author(s) -
Bernardino Rampone,
Beniamino Schiavone,
Antonio Martino,
Carmine Viviano,
G Confuorto
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.3210
Subject(s) - hepatocellular carcinoma , medicine , malignancy , liver transplantation , curative treatment , carcinoma , disease , intensive care medicine , transplantation , general surgery , surgery , oncology
Hepatocellular carcinoma (HCC) still remains a considerable challenge for surgeons. Surgery, including liver transplantation, is the most important therapeutic approach for patients with this disease. HCC is frequently diagnosed at advanced stages and has a poor prognosis with a high mortality rate even when surgical resection has been considered potentially curative. This brief report summarizes the current status of the management of this malignancy and includes a short description of new pharmacological approaches in HCC treatment.